ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,470Medicare Part D Prescriptions Filled, Including Refills

Rank: 132 out of 930

$741K Total Retail Price of All Prescriptions

Rank: 37 out of 930

392 Patients Receiving at Least One Drug in Part D
94% Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Washington
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 392 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 392 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 410 405* 101 1 1
SIMVASTATIN 379 374* 97 2 3
ATORVASTATIN CALCIUM 310 305* 76 3 6
CITALOPRAM HBR 286 268 55 4 17
OMEPRAZOLE 279 260 65 5 4
LEVOTHYROXINE SODIUM 251 236 55 6 2
PREDNISONE 232 212 86 7 38
LOSARTAN POTASSIUM 223 223 53 8 11
FUROSEMIDE 195 190* 49 9 8
WARFARIN SODIUM 193 188* 39 10 12
CARVEDILOL 188 188 39 11 33
FLUTICASONE PROPIONATE 185 180* 75 12 24
ALLOPURINOL 160 160 30 13 30
HYDROCHLOROTHIAZIDE 158 147 44 14 10
MONTELUKAST SODIUM 157 152* 39 15 71
AMLODIPINE BESYLATE 151 146* 36 16 5
TAMSULOSIN HCL 146 141* 33 17 23
ATENOLOL 138 133* 37 18 15
METFORMIN HCL 122 117* 34 19 9
GABAPENTIN 122 122 35 19 14
HYDROCODONE-ACETAMINOPHEN 121 116* 33 S3 21 7
METOPROLOL SUCCINATE 120 115* 33 22 18
ZOLPIDEM TARTRATE 91 91 20 23 25
PANTOPRAZOLE SODIUM 88 83* 19 24 39
AZITHROMYCIN 85 73 57 25 66
PROAIR HFA 83 78* 45 26 35
CLOPIDOGREL 80 80 19 27 28
OXYCODONE HCL 77 47 13 S2 28 27
TRAZODONE HCL 75 70* 15 29 22
CRESTOR 73 73 24 30 37
NEXIUM 72 67* 17 31 67
MELOXICAM 67 67 18 32 53
SYNTHROID 66 61* 18 33 63
NABUMETONE 66 66 28 33 189
LOSARTAN-HYDROCHLOROTHIAZIDE 65 65 14 35 57
POTASSIUM CHLORIDE 65 60* 18 35 16
CIPROFLOXACIN HCL 64 64 47 37 72
LANTUS SOLOSTAR 63 63 11 38 56
BENAZEPRIL HCL 60 <11 <11 39 86
METOPROLOL TARTRATE 57 52* 17 40 13
METFORMIN HCL ER 57 52* 16 40 65
SPIRIVA 56 51* 16 42 48
TRAMADOL HCL 56 42 12 42 26
ADVAIR DISKUS 55 44 14 44 50
DICLOFENAC SODIUM 55 55 28 44 110
BD ULTRA-FINE PEN NEEDLE 51 46* 13 46 124
HYDROXYCHLOROQUINE SULFATE 51 46* 11 46 216
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.